Trial intelligence / Profile preview

Antibiotic Prophylaxis in Ear Surgery

NCT04707092Phase 4Unknown

Sponsor
Sunnybrook Health Sciences Centre
Start
Jun 2021
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of amoxicillin + clavulanate in surgical site infection (SSI), sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Adverse events at 1 month. Status: unknown.

02

Drugs

amoxicillin + clavulanate
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT04707092.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04707092.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call